Pediatric drug safety signal detection of non-chemotherapy drug-induced neutropenia and agranulocytosis using electronic healthcare records

References

• Osokogu OU, Fregonese F, Ferrajolo C, et al. Pediatric drug safety signal detection: a new drug–event reference set for performance testing of data-mining methods and systems. Drug Saf. 2015;38(2):207–217. doi: 10.1007/s40264-015-0265-0. PubMed PMID: 25663078; PubMed Central PMCID: PMCPMC4328124. eng.
   PubMed Web of Science ®Google Scholar
• Conroy S. Unlicensed and off-label drug use: issues and recommendations. Paediatr Drugs. 2002;4(6):353–359. PubMed PMID: 12038871.
   PubMedGoogle Scholar
• Okada N, Niimura T, Zamami Y, et al. Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR-ABL inhibitor use by using an adverse drug event reporting database. Cancer Med. 2019 Jan;8(1):174–181. PubMed PMID: 30561126; PubMed Central PMCID: PMCPMC6346261. eng.
   PubMed Web of Science ®Google Scholar
• Härmark L, Van Grootheest A. Pharmacovigilance: methods, recent developments and future perspectives. Eur J Clin Pharmacol. 2008;64(8):743–752.
   PubMed Web of Science ®Google Scholar
• Overview of neutropenia in children and adolescents [2019 Feb 15; cited 2019 Mar 24]. Available from: https://www.uptodate.com/contents/zh-Hans/overview-of-neutropenia-in-children-and-adolescents?search=neutropenia&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2
   Google Scholar
• Arber DA, Glader B, List AF, et al. Wintrobe‘s clinical hematology. Philadelphia, US: Lippincott Williams & Wilkins; 2013.
   Google Scholar
• Kaufman DW, Kelly JP, Jurgelon JM, et al. Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol. 1996;57(S60):23–30.
   Google Scholar
• Bar-Joseph G, Halberthal M, Sweed Y, et al. Clostridium septicum infection in children with cyclic neutropenia. J Pediatr. 1997;131(2):317–319.
   PubMed Web of Science ®Google Scholar
• Ramirez E, Carcas A, Borobia A, et al. A pharmacovigilance program from laboratory signals for the detection and reporting of serious adverse drug reactions in hospitalized patients. Clin Pharmacol Ther. 2010;87(1):74–86.
   PubMed Web of Science ®Google Scholar
• Haerian K, Varn D, Vaidya S, et al. Detection of pharmacovigilance‐related adverse events using electronic health records and automated methods. Clin Pharmacol Ther. 2012;92(2):228–234.
   PubMed Web of Science ®Google Scholar
• Yoon D, Park M, Choi N, et al. Detection of adverse drug reaction signals using an electronic health records database: Comparison of the Laboratory Extreme Abnormality Ratio (CLEAR) algorithm. Clin Pharmacol Ther. 2012;91(3):467–474.
   PubMed Web of Science ®Google Scholar
• Medrano-Casique N, Tong HY, Borobia AM, et al. Nonchemotherapy drug-induced agranulocytosis in children detected by a prospective pharmacovigilance program. Pediatr Hematol Oncol. 2016;33(7–8):441–456.
   PubMed Web of Science ®Google Scholar
• De Bie S, Coloma PM, Ferrajolo C, et al. The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study. Br J Clin Pharmacol. 2015;80(2):304–314.
   PubMed Web of Science ®Google Scholar
• Boxer LA. How to approach neutropenia. ASH Educ Program Book. 2012;2012(1):174–182.
   Google Scholar
• Harpaz R, Dumouchel W, Shah NH, et al. Novel data-mining methodologies for adverse drug event discovery and analysis. Clin Pharmacol Ther. 2012;91(6):1010–1021.
   Google Scholar
• Antiviral drugs-information for health care professionals: Centers for Disease Control; [updated 2018-12-27; cited 2019 Feb 15]. Available from: https://www.cdc.gov/flu/professionals/antivirals/
   Google Scholar
• WHO Model List of Essential Medicines: 20th List: World Health Organization; [updated 2017-08; cited 2019 Feb 15]. Available from: https://www.who.int/medicines/publications/essentialmedicines/en/
   Google Scholar
• Shenfield G, Spry C. Unusual cause of agranulocytosis. Br Med J. 1968;2(5596):52.
   Google Scholar
• Hardin AS. Chlorpheniramine and agranulocytosis. Ann Intern Med. 1988;108(5):770.
   PubMed Web of Science ®Google Scholar
• Motola D, Donati M, Biagi C, et al. Safety profile of H1‐antihistamines in pediatrics: an analysis based on data from VigiBase. Pharmacoepidemiol Drug Saf. 2017;26(10):1164–1171.
   PubMed Web of Science ®Google Scholar
• Hohl CM, Karpov A, Reddekopp L, et al. ICD-10 codes used to identify adverse drug events in administrative data: a systematic review. J Am Med Inform Ass. 2014;21(3):547.
   Google Scholar
• Lin C, Karlson EW, Dligach D, et al. Automatic identification of methotrexate-induced liver toxicity in patients with rheumatoid arthritis from the electronic medical record. J Am Med Inform Ass. 2014;22(e1):e151.
   Google Scholar
• Stang PE, Ryan PB, Dusetzina SB, et al. Health outcomes of interest in observational data: issues in identifying definitions in the literature. Health Outcomes Res in Med. 2012;3(1):e37–e44.
   Google Scholar
• Schuemie MJ. Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD. Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):292–299. PubMed PMID: 20945505; eng.
   PubMed Web of Science ®Google Scholar
• Carmen F, Coloma PM, Verhamme KMC, et al. Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network. Drug Saf. 2014;37(2):99.
   Google Scholar
• Collaborators A, Andersen M, Bergman U, et al. The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia. Pharmacoepidemiol Drug Saf. 2013;22(7):700–704.
   PubMed Web of Science ®Google Scholar
• Platt R, Carnahan RM, Brown JS, et al. The U.S. food and drug administration‘s mini-sentinel program: status and direction. Pharmacoepidemiol Drug Saf. 2012;21(SupplementS1):1–8.
   PubMedGoogle Scholar
• Stang PE, Ryan PB, Racoosin JA, et al. Advancing the science for active surveillance: rationale and design for the observational medical outcomes partnership. Ann Intern Med. 2010;153(9):600–606.
   PubMed Web of Science ®Google Scholar
• Trifiro G, Fourrier-Reglat A, Sturkenboom MC, et al. The EU-ADR project: preliminary results and perspective. Stud Health Technol Inform. 2009;148(148):43.
   Google Scholar